S chistosomiasis is endemic in 70 countries and aff f fects more than 200 million people worldwide. 1 The mortality associated with S. mansoni infecf f tion is mostly due to the development of Symmers' perif f portal fibrosis (PPF), and subsequent portal hypertenf f sion and development of esophageal varices, which also cause significant morbidity. 2, 3 In Sudan the prevalence of infection with S. mansoni in endemic areas such as the Gezira and White Nile regions may reach up to 70% and PPF up to 18% in areas not covered by conf f trol programs. 4 Data on the prevalence of gastric varices and portal hypertensive gastropathy (PHG) in patients with Symmers' periportal fibrosis, a common cause of portal hypertension worldwide, remains relatively scarce as most studies were conducted in patients with portal hypertension secondary to liver cirrhosis. The prevalence of gastric varices in cirrhotic patients varies from 20% to 57% in previous studies. 5, 6 Gastric varices are associated with fewer but more severe episodes of Prevalence of gastric varices and portal hypertensive gastropathy in patients with Symmers' periportal fibrosis BACKGROUND AND OBJECTIVE: Symmers' periportal fibrosis secondary to schistosomiasis is a common cause of portal hypertension worldwide. Data on the prevalence of gastric varices and portal hypertensive gastropathy in this group of patients with portal hypertension is relatively scarce. The aim of this study was to determine the prevalence of gastric varices and portal hypertensive gastropathy in patients presenting with portal hypertension secondary to Symmers' periportal fibrosis.
PATIENTS AND METHODS:
In a prospective study, upper gastrointestinal endoscopy was carried out to deter--mine the prevalence of gastric varices and portal hypertensive gastropathy in patients with portal hypertension secondary to Symmers' periportal fibrosis. RESULTS: Of 143 patients studied, 24 patients (16.8%) had gastric varices (grade I in 10.5%, grade II in 6.3%) and 31 patients (21.7%) had portal hypertensive gastropathy (mild in 11.2%, severe in 10.5%). Gastric varices were more prevalent in patients with grade I and II esophageal varices and portal hypertensive gastropathy was more prevalent in those with grade III and IV esophageal varices, but the differences were not statiscally signi--fant. CONCLUSION: We concluded that both gastric varices and portal hypertensive gastropathy seem to have a low--er prevalence in patients with portal hypertension secondary to Symmers' periportal fibrosis when compared to reported data in patients with portal hypertension secondary to liver cirrhosis and non-cirrhotic portal fibrosis.
bleeding than esophageal varices; they may bleed in up to 20% of patients and bleeding is more difficult to conf f trol. 5 The prevalence of PHG varies greatly, from 9% to 98%, and bleeding from PHG is generally uncomf f mon and rarely severe and tends to be chronic rather than acute. 7 The prevalence of gastric varices and PHG tends to increase following esophageal sclerotherapy or band ligation. 7 This study was conducted to determine the prevalence of gastric varices and portal hypertensive gastropathy in patients with portal hypertension secf f ondary to Symmers' periportal fibrosis.
PATIENTS AND METHODS
This was a prospective, descriptive, hospitalfbased study conducted at Soba University Hospital, Khartoum, Sudan, during the period from March 2003 to July 2004. All patients with portal hypertension secondary to Symmers' PPF referred for elective upper GI enf f doscopy were enrolled in the study if they fulfilled the following criteria: 1) residence in an endemic area for intestinal schistosomiasis for more than 10 years, 2) a history of S. mansoni infection, 3) features of PPF on abdominal ultrasonography, 8, 9 4) a portal vein diameter of >13 mm on abdominal ultrasound and 5) a platef f let count of <100 000. Exclusion criteria included the following: 1) biochemical or ultrasonographic features of portal hypertension due to causes other than PPF such as liver cirrhosis, 2) PPF with previous endoscopic esophageal therapy such as band ligation or sclerof f therapy or prophylactic pharmacological therapy such as ß blockers, 3) positive serology for HBsAg or HCV antibodies or 4) malignancy. The study was approved by the medical research board, Faculty Of Medicine, University of Khartoum and all patients were included in the study after giving informed consent.
All patients underwent an upper GI endoscopy using an Olympus GIF XQ 240 video gastroscope to assess (a) the presence and grade of esophageal varif f ces from grade IfIV according to Paquet et al, 10 and (b) the type of gastric varices from IfIII according to Hosking and Johnson 11 with type I gastric varices havf f ing an inferior extension of esophageal varices across the squamocolumnar junction, type II gastric varices located in the fundus of the stomach and nearly always accompanied by esophageal varices and type III gastric varices located in the fundus or body of the stomach in the absence of esophageal varices , and (c) the presf f ence and degree of portal hypertensive gastropathy as described by McCormack et al 12 into mild, those with fine pink speckling and a snake skin striped appearance and severe being those with discrete red spots and diff f fuse hemorrhagic gastritis.
The χ 2 test with Yates' correction was used to comf f pare proportions. The odds ratio (OR) with 95% confif f dence intervals were calculated either directly or by the MantelfHaenszel method for stratified analysis.
RESULTS
A total of 200 patients with portal hypertension pref f sented to the endoscopy unit during the study period, and 57 were excluded from the study as follows: 35 patients had liver cirrhosis, 12 patients had positive sef f rology for HBsAg or HCV antibodies, 4 patients had hepatocellular carcinoma, 4 patients had previous endof f scopic esophageal therapy, 1 patient had BuddfChiari syndrome and 1 patient had splenic vein thrombosis. Only 143 patients presenting with portal hypertension secondary to Symmers' PPF were included in the study. The mean age of the study group was 42 years with an age range of 15 to 75 years and 82% were males (Table  1 ). All had esophageal varices on endoscopy, 5% had grade I varices, 31% had grade II varices, 58% had grade III varices and 6% had grade IV varices.
Gastric varices were detected in 24 patients (16.8%), 10.5% had type I varices (grade I) and 6.3% had type II varices (grade II) ( Table 2 ). Patients with grade I and II esophageal varices had the highest prevalence of gastric varices but the differences were not statistif f cally significant. Portal hypertensive gastropathy was detected in 31 patients (21.7%), and was of mild degree 
